A multi-parameter, high-content, high-throughput screening platform to identify natural compounds that modulate insulin and Pdx1 expression.
Diabetes is a devastating disease that is ultimately caused by the malfunction or loss of insulin-producing pancreatic beta-cells. Drugs capable of inducing the development of new beta-cells or improving the function or survival of existing beta-cells could conceivably cure this disease. We report a...
Guardado en:
Autores principales: | Jessica A Hill, Marta Szabat, Corinne A Hoesli, Blair K Gage, Yu Hsuan C Yang, David E Williams, Michael J Riedel, Dan S Luciani, Tatyana B Kalynyak, Kevin Tsai, Ziliang Ao, Raymond J Andersen, Garth L Warnock, James M Piret, Timothy J Kieffer, James D Johnson |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4597d03eed1c4485a31e9ca5441e029a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pancreatic islets in bed with microvasculature—companions for life
por: Corinne A. Hoesli, et al.
Publicado: (2021) -
Epigenetic Regulation of PDX-1 in Type 2 Diabetes Mellitus
por: Liu J, et al.
Publicado: (2021) -
Chemiplasmonics for high-throughput biosensors
por: Raghavendra AJ, et al.
Publicado: (2018) -
Compression of structured high-throughput sequencing data.
por: Fabien Campagne, et al.
Publicado: (2013) -
High-throughput targeted long-read single cell sequencing reveals the clonal and transcriptional landscape of lymphocytes
por: Mandeep Singh, et al.
Publicado: (2019)